Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E D Johansson

Showing results (1-10 of 168) with videos related to

Pageof 17
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375)E D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1984
The sterile menstrual cycle. The driving force behind pathology in the reproductive organsE D Johansson
Proceedings of the Royal Society of London. Series B, Biological Sciences|December 10, 1976
Advantages and disadvantages of the intrauterine device and the hormone implantE D Johansson
Nordisk Medicin|April 8, 1971
[Progesterone and estrogen levels in plasma during implantation in man]E D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1972
Plasma levels of progesterone achieved by different routes of administrationE D Johansson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1973
Plasma levels of progesterone and oestradiol after injections of 17 -hydroxyprogesterone caproate during the luteal phase of the normal menstrual cycleE D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1971
Luteolytic effect of gestagensE D Johansson
Clinics in Obstetrics and Gynaecology|December 1, 1976
Effects of exogenous steroids on gonadotrophin secretionE D Johansson
Review of Law and Social Change. New York University|January 1, 1997
Comparison of the availability of contraceptive methods in selected European countries and the United StatesE D Johansson
Steroids|December 8, 2000
The return of the pharmaceutical industry to the market of contraceptionE D Johansson
Pageof 17

Showing results (1-10 of 168) with videos related to

Sort By:
Pageof 17
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1975
Plasma levels of progesterone and oestrogens in women treated with an oral contraceptive of low oestrogen content (Ovostat 1375)E D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1984
The sterile menstrual cycle. The driving force behind pathology in the reproductive organsE D Johansson
Proceedings of the Royal Society of London. Series B, Biological Sciences|December 10, 1976
Advantages and disadvantages of the intrauterine device and the hormone implantE D Johansson
Nordisk Medicin|April 8, 1971
[Progesterone and estrogen levels in plasma during implantation in man]E D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1972
Plasma levels of progesterone achieved by different routes of administrationE D Johansson
Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1973
Plasma levels of progesterone and oestradiol after injections of 17 -hydroxyprogesterone caproate during the luteal phase of the normal menstrual cycleE D Johansson
Acta Obstetricia Et Gynecologica Scandinavica. Supplement|January 1, 1971
Luteolytic effect of gestagensE D Johansson
Clinics in Obstetrics and Gynaecology|December 1, 1976
Effects of exogenous steroids on gonadotrophin secretionE D Johansson
Review of Law and Social Change. New York University|January 1, 1997
Comparison of the availability of contraceptive methods in selected European countries and the United StatesE D Johansson
Steroids|December 8, 2000
The return of the pharmaceutical industry to the market of contraceptionE D Johansson
Pageof 17